まとめ
酸素濃縮空気 (FIO2 0.40) を投与すると,犬の冠動脈閉塞に伴う心筋梗塞のサイズと急性性缺血性損傷が著しく減少します. 酸素濃度の上昇は,酵素学的および組織学的評価によって確認されたように,死滅の進行を遅らせます.
科学分野:
- 心血管研究 循環器科の研究
- 酸素療法による酸素療法です.
- 心筋梗塞 (Myocardial Infarction) とは心筋梗塞 (Myocardial Infarction) とは心筋梗塞 (Myocardial Infarction) とは心筋梗塞 (Myocardial Infarction) とは心筋梗塞 (Myocardial Infarction) とは心筋梗塞 (Myocardial Infarction) とは心筋梗塞 (Myocardial Infarction) とは心筋梗塞 (Myocardial Infarction) とは心筋梗塞 (Myocardial Infarction) とは心筋梗塞 (Myocardial Infarction) とは心筋梗塞 (Myocardial Infarction) とは心筋梗塞 (Myocardial Infarction) とは心筋梗塞 (Myocardial Infarction) とは
背景:
- 心筋梗塞 (MI) は死亡の主な原因である.
- 酸素療法 (oxygen therapy) は,心血管疾患の緊急事態における一般的な介入である.
- 酸素濃度の変動が心臓発作のサイズに与える正確な影響については,さらなる解明が必要である.
研究 の 目的:
- 実験用の犬のモデルで心筋梗塞の大きさに酸素濃縮された空気の影響を調査する.
- 吸入酸素分数 (FIO2) を増加させることで,急性缺血性損傷およびその後の心筋死滅が軽減されるかどうかを判断する.
主な方法:
- 冠動脈閉塞を受けた麻酔を受けた犬の心筋不全性損傷を評価するために,エピカルディアル電図を用いた.
- 犬は,閉塞の間,酸素を吸入した酸素の異なる分数 (FIO2 0.20 と 0.40) に暴露されました.
- 心筋クリエチンフォスフォキナーゼ (CPK) の活性と組織学的技術を使用して,24時間後に心臓発作の大きさを評価した.
主要な成果:
- 0.40のFIO2は,STセグメントの上昇を著しく減少させ,FIO2 0.20 (P < 0.01) と比較して,著しく上昇した部位の数を大幅に減少させた.
- 閉塞後のFIO2を0.40に上昇させると,CPK活動が低下し,心臓発作の発生率が低下した (49%対100%対照群).
- 1.0のFIO2は,心筋損傷のさらなる減少をもたらさなかった.
結論:
- 0.40のFIO2で吸入された酸素は,実験的な冠動脈閉塞後の急性性性血栓損傷を効果的に減少させます.
- 酸素濃縮空気の投与は,酵素学的および組織学的発見によって証明されているように,心筋縮の最終的な発展を減少させます.
- この発見は,急性心筋不全症の間,心臓発作の大きさを制限する中等度の高酸素症の治療上の利点を示唆しています.
さらに関連する動画
09:12Surgical Swine Model of Chronic Cardiac Ischemia Treated by Off-Pump Coronary Artery Bypass Graft Surgery
Published on: March 27, 2018
08:35Oxygenation-sensitive Cardiac MRI with Vasoactive Breathing Maneuvers for the Non-invasive Assessment of Coronary Microvascular Dysfunction
Published on: August 17, 2022
関連する概念動画
Imbalances in Cardiac Output
The heart's primary function is to pump blood throughout the body, maintaining a balance between blood sent out (cardiac output) and blood returning (venous return). If this balance is disrupted, it can result in congestive heart failure (CHF), a severe condition where the heart becomes an inefficient pump, leading to inadequate blood circulation.
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send blood...
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send blood...
Pneumothorax-I
A pneumothorax is a condition where air builds up in the space between the lung and the chest wall, causing the lung to collapse. This condition arises when air enters the space between the parietal and visceral pleura, disrupting the negative pressure essential for lung inflation. This can lead to a partial or complete collapse of the lung.
Pneumothorax can be even further classified as spontaneous, traumatic, and tension pneumothorax.
Pneumothorax can be even further classified as spontaneous, traumatic, and tension pneumothorax.
Mitral Stenosis IV: Nursing Management
A comprehensive nursing assessment is essential for patients with valvular heart disease, which involves any dysfunction of the heart valves that could impact blood flow and overall heart function.Subjective Data Collection:Chief Complaint and Present Illness: Start with the patient's primary concerns, focusing on the onset, duration, and progression of cardiac symptoms such as dyspnea, fatigue, chest pain, and palpitations.Past Medical History: Collect detailed information on any previous...
Aortic Regurgitation III: Medical Management
Aortic regurgitation (AR) is when the aortic valve does not close or seal properly, leading to backward blood circulation from the aorta into the left ventricle during diastole. Common causes of AR include rheumatic heart disease, congenital valve defects, and aortic root dilation. Managing AR requires a multifaceted approach to alleviate symptoms, preserve left ventricular function, and address the underlying cause of the regurgitation. Patients with symptomatic AR or significant left...
Coronary Artery Disease V: Interprofessional Care
Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
Acute Coronary Syndrome V: Nursing Management
Nursing Assessment:Nursing management of acute coronary syndrome (ACS) involves taking the patient's history, focusing on primary complaints such as chest pain, dyspnea, and excessive sweating (diaphoresis), as well as other symptoms like back or jaw pain, nausea, vomiting, palpitations, dizziness, and fatigue. The nurse also reviews the patient's history of cardiac events, risk factors such as hypertension, diabetes, smoking, family history, and current medications.In the objective assessment,...
